Frank Witney Joins Cerus Board of Directors
March 25, 2014
CONCORD, Calif.-- Cerus Corporation (NASDAQ: CERS) announced today that Dr. Frank Witney, president and chief executive officer of Affymetrix, has joined its board of directors and the compensation committee. Dr. Witney joins the board with over 30 years of experience in the life science industry, specifically focused on corporate strategy and commercialization of products in [...]
CGG and Baker Hughes Sign Exclusive Long-term RoqSCAN Agreement as Part of Shale Science Alliance
March 25, 2014
HOUSTON -- Baker Hughes Incorporated (NYSE: BHI) announced today that it has signed an exclusive agreement with CGG (NYSE/Euronext: CGG) for RoqSCAN™ technology offered by CGG. RoqSCAN is a real-time, fully portable, quantitative and automated rock properties and mineralogical analyzer. Developed by Robertson, a CGG company, and Carl Zeiss Microscopy Ltd., RoqSCAN delivers highly quantitative [...]
Syapse Launches Features for Integrating With Popular Interpretation Providers
March 25, 2014
PALO ALTO, Calif. and NASHVILLE, Tenn. – Syapse, the leading provider of software for bringing omics data into routine medical use, announced today at the American College of Medical Genetics (ACMG) Annual Meeting that it will enable popular third-party commercial omics interpretation providers to make their content available to Syapse customers through the Syapse platform. [...]
EMD Millipore launches new kits for use on Gyros’ immunoassay platform
March 25, 2014
Uppsala, Sweden — Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, today announced that EMD Millipore, Life Science division of Merck KGaA of Darmstadt, Germany, has released five new immunoassay kits designed specifically for use on Gyrolab™ xP workstation. The new, fully qualified GyroMark™ HT kits from EMD Millipore [...]
Genetic Technologies Executes Agreement with Promega Corporation
March 24, 2014
In compliance with the ASX Continuous Disclosure Rules, Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to report it has now executed a Settlement, Covenant and License Agreement with Promega Corporation, which has a principal place of business in Madison, Wisconsin, USA. Under this Agreement, GTG grants broad rights to Promega in relation to [...]
March 24, 2014
COLUMBIA, Md. - W. R. Grace & Co. (NYSE: GRA) has introduced ProVance™ pre-packed columns, a portfolio of products for cost-effective purification of biologic drugs, specifically monoclonal antibodies (mAbs). Monoclonal antibodies are key therapeutic agents used to treat rheumatoid arthritis, cancer and other diseases. Currently in the U.S., mAbs constitute the single largest biologics product [...]
March 24, 2014
METTLER TOLEDO Process Analytics Division has released the 450TOC Portable Total Organic Carbon Analyzer for use in pure water and ultrapure water treatment applications. High purity water is used across a variety of industries for many applications, ranging from a main ingredient in pharmaceutical and cosmetic products, washing and rinsing processes for microelectronics manufacturing, to [...]
Brooks Automation and BioCision Announce Equity Investment and Strategic Collaboration
March 24, 2014
CHELMSFORD, Mass. and LARKSPUR, Calif. -- Brooks Automation, Inc. (Nasdaq:BRKS), a global provider of automated sample storage systems for compound management and biorepositories, and BioCision, LLC, a leader in advanced technology to improve biomaterial sample handling and standardization, today announced they have established a relationship to support the development of technologies to improve temperature control [...]
Integrated DNA Technologies Advances Human Health and Clinical Research
March 24, 2014
CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is extending its portfolio of NGS panels with the addition of the xGen® Inherited Disease and Pan-Cancer Panels. Adding these to the xGen AML Panel which was launched at the end of last year, IDT now offers a range of panels for [...]
HEPREGEN LAUNCHES FIRST HUMAN HEPATOPACTM ASSAY KIT TO EVALUATE HEPATOTOXICITY IN THE LABORATORY
March 24, 2014
Phoenix, Arizona – Today, at the Society of Toxicology’s 53rd Annual Meeting, Hepregen Corporation, a leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based in vitro assay products announced the commercial launch of the company’s first HepatoPacTM kit designed specifically for toxicology applications. The kit contains one or more standard 96-well tissue culture [...]

